The European Medicines Agency said on Friday Eli Lilly's weight-loss drug Mounjaro does not need a separate approval for the ...
The most common adverse events reported with both treatments were mild to moderate gastrointestinal-related side effects.
A man who 'thought he was going to die' after using the 'King Kong' of weight loss injections is warning others of the ...
Data continue to show that tirzepatide, called Mounjaro for type 2 diabetes and Zepbound for weight loss, is safe and effective, but side effects remain.
Patients lost an average of 20.2% of their weight with tirzepatide over 72 weeks versus 13.7% with semaglutide.
Patients self-administer the drug using a pre-dosed injector pen, but Lilly recently introduced the product in single-dose ...
Zepbound, a drug with the main active ingredient tirzepatide, was found to be more helpful in helping people lose weight than ...
Weight loss jab tirzepatide – commonly sold under the brand name Mounjaro – is set to become available via the NHS for ...